21-45997781-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001848.3(COL6A1):​c.1524+19G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0868 in 1,569,514 control chromosomes in the GnomAD database, including 6,576 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.087 ( 639 hom., cov: 35)
Exomes 𝑓: 0.087 ( 5937 hom. )

Consequence

COL6A1
NM_001848.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.15

Publications

5 publications found
Variant links:
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]
COL6A1 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bethlem myopathy 1A
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 21-45997781-G-C is Benign according to our data. Variant chr21-45997781-G-C is described in ClinVar as Benign. ClinVar VariationId is 93821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.189 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A1NM_001848.3 linkc.1524+19G>C intron_variant Intron 22 of 34 ENST00000361866.8 NP_001839.2 P12109A0A384P5H7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A1ENST00000361866.8 linkc.1524+19G>C intron_variant Intron 22 of 34 1 NM_001848.3 ENSP00000355180.3 P12109
COL6A1ENST00000683550.1 linkn.299+19G>C intron_variant Intron 3 of 4

Frequencies

GnomAD3 genomes
AF:
0.0865
AC:
13161
AN:
152090
Hom.:
635
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0588
Gnomad AMI
AF:
0.169
Gnomad AMR
AF:
0.129
Gnomad ASJ
AF:
0.0729
Gnomad EAS
AF:
0.198
Gnomad SAS
AF:
0.0743
Gnomad FIN
AF:
0.107
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0825
Gnomad OTH
AF:
0.0970
GnomAD2 exomes
AF:
0.101
AC:
17918
AN:
177312
AF XY:
0.0970
show subpopulations
Gnomad AFR exome
AF:
0.0604
Gnomad AMR exome
AF:
0.144
Gnomad ASJ exome
AF:
0.0656
Gnomad EAS exome
AF:
0.201
Gnomad FIN exome
AF:
0.107
Gnomad NFE exome
AF:
0.0840
Gnomad OTH exome
AF:
0.108
GnomAD4 exome
AF:
0.0869
AC:
123101
AN:
1417306
Hom.:
5937
Cov.:
35
AF XY:
0.0863
AC XY:
60507
AN XY:
701214
show subpopulations
African (AFR)
AF:
0.0554
AC:
1800
AN:
32472
American (AMR)
AF:
0.143
AC:
5546
AN:
38832
Ashkenazi Jewish (ASJ)
AF:
0.0647
AC:
1643
AN:
25382
East Asian (EAS)
AF:
0.209
AC:
7828
AN:
37392
South Asian (SAS)
AF:
0.0704
AC:
5698
AN:
80984
European-Finnish (FIN)
AF:
0.103
AC:
5075
AN:
49324
Middle Eastern (MID)
AF:
0.104
AC:
492
AN:
4714
European-Non Finnish (NFE)
AF:
0.0824
AC:
89773
AN:
1089600
Other (OTH)
AF:
0.0895
AC:
5246
AN:
58606
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
5377
10753
16130
21506
26883
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3392
6784
10176
13568
16960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0866
AC:
13177
AN:
152208
Hom.:
639
Cov.:
35
AF XY:
0.0876
AC XY:
6519
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.0587
AC:
2440
AN:
41556
American (AMR)
AF:
0.129
AC:
1971
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0729
AC:
253
AN:
3472
East Asian (EAS)
AF:
0.199
AC:
1023
AN:
5148
South Asian (SAS)
AF:
0.0745
AC:
360
AN:
4830
European-Finnish (FIN)
AF:
0.107
AC:
1133
AN:
10616
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0826
AC:
5611
AN:
67958
Other (OTH)
AF:
0.100
AC:
212
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
647
1294
1941
2588
3235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0432
Hom.:
45
Bravo
AF:
0.0883
Asia WGS
AF:
0.155
AC:
539
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 31, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 25, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Bethlem myopathy 1A Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.010
DANN
Benign
0.34
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276256; hg19: chr21-47417695; COSMIC: COSV62612072; COSMIC: COSV62612072; API